Simpler HIV treatment tested specifically for trans women
NCT ID NCT06967753
Summary
This study is testing whether a simpler, two-drug HIV treatment works well for transgender women who already have their virus under control with standard three-drug therapy. Researchers will switch 50 participants to the two-drug combination and follow them for 48 weeks to see if it remains effective, is safe, and is acceptable. The goal is to see if this simpler regimen can maintain control of HIV while potentially reducing side effects and improving quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital General de Agudos Dr. Juan A. Fernández, Infectious Diseases Division
RECRUITINGBuenos Aires, Buenos Aires F.D., 1425, Argentina
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.